Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06399952 · ClinicalTrials.gov registry record
Baker Gordon Syndrome Natural History Study
A clinical trial of Sleep Disorder and Rare Diseases, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06399952 is a study of Sleep Disorder and Rare Diseases that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 50 participants, below the 160-participant average among 22 other Sleep Disorder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06399952, a study of Sleep Disorder and Rare Diseases, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder also known as Baker Gordon Syndrome (BAGOS). This will be performed by acquiring baseline measurements and developing effective outcome measures and diagnostic tools for the disorder, to prepare the healthcare system for future clinical trials.
Conditions Studied
Interventions
- GENETIC Whole Genome Sequencing
- DIAGNOSTIC_TEST Brain Magnetic Resonance Imaging (MRI)
- OTHER Induced Pluripotential Stem Cells
Study Locations (1)
Missouri
- University of Missouri Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2026-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06399952
The ClinicalTrials.gov registry entry for NCT06399952 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 22 other Sleep Disorder trials with a reported enrollment target (69% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Sleep Disorder appearing as the primary indexed condition, and to 3 interventions - of which Whole Genome Sequencing is the first listed.
NCT06399952 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06399952 about?
NCT06399952 is a clinical study titled "Baker Gordon Syndrome Natural History Study". The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder also known as Baker Gordon Syndrome (BAGOS). This will be performed by acquiring baseline measurements and...
What is the current status of trial NCT06399952?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-04-30. Estimated completion is 2026-05-05.
What conditions does trial NCT06399952 study?
This clinical trial studies the following conditions: Sleep Disorder, Rare Diseases, Development Delay, Motor Delay, Epilepsy, Generalized.
What interventions are being tested in trial NCT06399952?
The interventions under investigation include: Whole Genome Sequencing (GENETIC), Brain Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST), Induced Pluripotential Stem Cells (OTHER).
Who is sponsoring clinical trial NCT06399952?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06399952 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
RECRUITING · Phase 3
-
Study of Disrupted Sleep in Somali Americans
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.